XML 60 R42.htm IDEA: XBRL DOCUMENT v3.24.3
REVENUE - Schedule of Disaggregated Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Total net product sales $ 168,573 $ 163,926 $ 513,713 $ 493,734
EXPAREL        
Disaggregation of Revenue [Line Items]        
Total net product sales 132,004 128,667 401,286 394,202
ZILRETTA        
Disaggregation of Revenue [Line Items]        
Total net product sales 28,420 28,798 84,966 82,393
iovera°        
Disaggregation of Revenue [Line Items]        
Total net product sales 5,655 5,260 16,359 13,645
Bupivacaine liposome injectable suspension        
Disaggregation of Revenue [Line Items]        
Total net product sales 1,643 858 7,322 2,241
Total net product sales        
Disaggregation of Revenue [Line Items]        
Total net product sales $ 167,722 $ 163,583 $ 509,933 $ 492,481